Bernhard Auerbach
Aventis Pharma
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bernhard Auerbach.
Cancer | 1993
Gabriele Jaques; Bernhard Auerbach; Maria Pritsch; Martin Wolf; Norbert Madry; Klaus Havemann
Background. Small cell lung cancer (SCLC) is distinguished from other histologic types of lung cancer by possessing a variety of neuroendocrine properties. Neuron‐specific enolase (NSE) is the most frequently elevated tumor marker for patients with SCLC at diagnosis. To assess the value of neural cell adhesion molecules (NCAM), another possible tumor marker for small cell lung cancer, NCAM was evaluated in the sera of patients with histologically confirmed SCLC in two prospective multicenter trials.
International Journal of Cancer | 1993
H. Friess; M. Büchler; Bernhard Auerbach; Alexander Weber; P. Malfertheiner; Kai Hammer; Norbert Madry; Sabine Greiner; Klaus Bosslet; Hans G. Beger
Archive | 1995
Klaus Bosslet; Peter Hermentin; Hans Harald Sedlacek; Bernhard Auerbach; Peter Pfleiderer; Rolf Müller
Archive | 1990
Klaus Bosslet; Gerhard Seemann; Hans-Harald Sedlacek; Bernhard Auerbach
Archive | 1991
Klaus Bosslet; Bernhard Auerbach; Helmut Peters
Archive | 1991
Bernhard Auerbach; Klaus Bosslet; Helmut Peters
Archive | 1994
Klaus Bosslet; Gerhard Seemann; Hans Harald Sedlacek; Bernhard Auerbach
Archive | 1991
Klaus Bosslet; Peter Hermentin; Hans Harald Sedlacek; Bernhard Auerbach; Peter Pfleiderer; Rolf Müller
Archive | 1995
Klaus Bosslet; Bernhard Auerbach; Helmut Peters
Archive | 1991
Klaus Bosslet; Peter Hermentin; Hans Harald Sedlacek; Bernhard Auerbach; Peter Pfleiderer; Rolf Müller
